66 /100
HIGH RISK
Score updated Jul 13, 2026

CNBX — CNBX Pharmaceuticals Inc. Dilution Risk Tracker

Track CNBX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CNBX — Get alerts when the score changes →

As of July 13, 2026, CNBX Pharmaceuticals Inc. (CNBX) has a DilutionWatch DilutionScore of 66/100, rated HIGH dilution risk. CNBX Pharmaceuticals Inc. has a market capitalization of $245.2K, 1.61B shares outstanding. Key dilution vectors include approximately 0 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
27
⚠️ Warrant Exposure
40
🔄Convertible Debt—

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
48%
🔁 Convertible Conversion 60%
• Major convertible overhang: 65% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise 55%
• Critical: only 0.4 months cash remaining
📉 Score Deterioration 10%
• Score in HIGH risk zone (66/100)
🔔 Track CNBX — Get forecast alerts →

💹 Market Data

Market Cap$245.2K
Shares Outstanding1.61B
Float1.23B
Cash$9.5K
Debt$120.0K
Short InterestN/A

🏛 Institutional Holdings

8.2% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track CNBX for full holder detail →

📉 Short Interest

Short Interest283.2K
Days to Cover1.0
% of Float0.0%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jul 07, 2026
xbrl XBRL CONVERTIBLE May 31, 2026
Full SEC filing analysis available with free account →

📰 Recent News

No recent news

📋 What This Means for CNBX Shareholders

CNBX Pharmaceuticals Inc. (CNBX) has a DilutionScore of 66/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 13, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: CNBX has approximately 0 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for CNBX in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for CNBX alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track CNBX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CNBX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

AGMH ALLR AMSS APC APRE

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for CNBX
📊 CNBX FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 CNBX Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.